Treatment of Angiofibromas in Tuberous Sclerosis Complex: The Effect of Topical Rapamycin and Concomitant Laser Therapy

被引:28
作者
Park, Jin [1 ,2 ]
Yun, Seok-Kweon [1 ,2 ]
Cho, Yong-Sun [1 ]
Song, Ki-Hun [1 ]
Kim, Han-Uk [1 ,2 ]
机构
[1] Chonbuk Natl Univ, Sch Med, Dept Dermatol, Jeonju 561712, South Korea
[2] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Biochem Res Inst, Res Inst Clin Med, Jeonju 561712, South Korea
关键词
Facial angiofibromas; Laser; Topical rapamycin; Tuberous sclerosis complex; FACIAL-ANGIOFIBROMAS;
D O I
10.1159/000357033
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Facial angiofibromas are the most troublesome cutaneous manifestations of the tuberous sclerosis complex and are difficult to treat. Lasers are most commonly used to treat these skin lesions, but results are disappointing with frequent recurrences. Recently, treatment of facial angiofibromas with topical rapamycin has been reported to yield promising results. We observed the need of laser ablation in addition to topical rapamycin to get best results for the treatment of angiofibromas in 4 cases. The result showed that topical rapamycin ointment was enough when the papules were yet small in size, i.e. less than a few millimeters, but additional laser ablation was needed for large papules approximately larger than 4 mm. Considering the natural course of facial angiofibromas, we believe that topical rapamycin can be best used in childhood patients. In adults, topical rapamycin was useful for treating the still present small papules and for preventing recurrences after laser treatment. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:37 / 41
页数:5
相关论文
共 12 条
[1]  
DeKlotz CMC, 2011, ARCH DERMATOL, V147, P1116, DOI 10.1001/archdermatol.2011.254
[2]   Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients [J].
Foster, Rachael S. ;
Bint, Lewis J. ;
Halbert, Anne R. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (01) :52-56
[3]  
Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125
[4]   Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: A double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin [J].
Mary Kay Koenig ;
Adelaide A. Hebert ;
Joan Roberson ;
Joshua Samuels ;
John Slopis ;
Audrey Woerner ;
Hope Northrup .
Drugs in R&D, 2012, 12 (3) :121-126
[5]   Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin [J].
McNamara, Elizabeth Kaufman ;
Curtis, Ashley R. ;
Fleischer, Alan B., Jr. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (01) :46-48
[6]   Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL-1) in two patients with tuberous sclerosis [J].
Mutizwa, M. M. ;
Berk, D. R. ;
Anadkat, M. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (04) :922-923
[7]   Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma [J].
Salido, R. ;
Garnacho-Saucedo, G. ;
Cuevas-Asencio, I. ;
Ruano, J. ;
Galan-Gutierrez, M. ;
Velez, A. ;
Moreno-Gimenez, J. C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (10) :1315-1318
[8]   Therapeutic targeting of mTOR in tuberous sclerosis [J].
Sampson, Julian R. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 :259-264
[9]   Tuberous sclerosis complex:: Advances in diagnosis, genetics, and management [J].
Schwartz, Robert A. ;
Fernandez, Geover ;
Kotulska, Katarzyna ;
Jozwiak, Sergiusz .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (02) :189-202
[10]  
Truchuelo Teresa, 2012, Dermatol Online J, V18, P15